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http:WHAT THIS PAPER ADDS
Data about association between obesity and chronic venous disease (CVD) and its clinical, etiologic, anatomic
and pathophysiologic (CEAP) C categories are inconsistent. In this study, the CEAP C category was signiﬁcantly
more advanced in overweight and obese patients and this relationship was independent from age, sex and other
confounding variables. Although the study design makes it difﬁcult to judge causal relations, it seems reasonable
to recommend weight reduction to overweight and obese patients with CVD. The results obtained could also be
useful for other investigations aimed to better understanding of CVD nature and consequently to better
prevention and/or treatment of the disease.Objectives: This study aims to investigate whether overweight and obesity are related to the clinical (C) category
of clinical, etiologic, anatomic and pathophysiologic (CEAP) classiﬁcation of chronic venous disease (CVD).
Design: A cross-sectional study.
Materials and methods: The study was conducted in Serbia, in the year 2011. Men and women aged >18 years,
consecutively coming to venous specialists because of venous problems in the legs, were included in the study.
Patients demographic, anthropometric and clinical data were collected. For the analysis, univariate and
multivariate logistic regressions were used.
Results: The study comprised 1116 subjects with primary CVD, 384 (34.4%) men and 732 (65.6%) women. Among
them 464 (41.6%) were normal-weight patients (body mass index (BMI) < 25.0 kg m2), 476 (42.7%) were
overweight (BMI ¼ 25.0e29.9 kg m2) and 176 (15.8%) were obese (BMI  30.0 kg m2). According to
multivariate analysis, the CEAP C category of CVD was signiﬁcantly more advanced in overweight and obese
patients, the association being more pronounced in obese. Compared groups did not differ in the presence of
venous reﬂux. In univariate analysis, venous obstruction was related to overweight and obesity but this
association did not substantially affect the relationship between obesity and CEAP C categories of CVD.
Conclusion: The CEAP C categories of CVD were signiﬁcantly related to overweight and obesity, and this
association was independent of age, sex and some other postulated risk factors.
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Western world.1,2 The cause of disease is probably multi-
factorial. Obesity has been suggested as one of the risk
factors for CVD, or an aggravating factor rather than the
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//dx.doi.org/10.1016/j.ejvs.2012.12.011obesity and CVD, as well as between obesity and severity of
CVD, are inconsistent.2e8 There are studies in which rela-
tionship between obesity and CVD was found in both
sexes4,7,8 and studies the results of which showed that body
mass index (BMI) was more important in women than in
men.2,3,5,6 There are also studies in which signiﬁcant asso-
ciation between obesity and severity of CVD was found.9e11
However, some authors found this association was age
linked e prevalence of both severe forms of CVD and
obesity increases with ageing.12
The aim of the present study was to investigate whether
overweight and obesity are related to the clinical (C)
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logic (CEAP) classiﬁcation of CVD.13
MATERIALS AND METHODS
The study was conducted in 14 towns in Serbia, in May 2011.
All men and women aged >18 years, consecutively coming
to venous specialists (a total of 47 specialists) because of
venous problems in the legs, were included in the study.
Written consent was obtained from all participants.
For each patient included in the study, the ‘Venous
specialist case report form’ designed for Step 2 of the Vein
Consult Program14 was fulﬁlled (The Vein Consult Program
was organised and sponsored by the Servier Company and
performed in co-operation with the International Union of
Phlebology). The following data were collected: demo-
graphic characteristics (age and sex); anthropometric and
lifestyle characteristics (weight, height and physical
activity); personal history of venous thrombosis, pulmonary
embolism and other health problems; present and previous
therapy of CVD; history of venous thrombosis, pulmonary
embolism and leg problems in patients parents as well as
the results of clinical examination of legs.
Diagnosis of CVD was made on the basis of symptoms,
clinical examination of lower limbs and ultrasound exami-
nation (Doppler ultrasound or a duplex scanning). Patients
were classiﬁed according to the C of the CEAP classiﬁcation
for chronic venous disorders.14 Diagnosis of CVD in patients
who were in the CEAP C0s category and without insufﬁ-
ciency or obstruction was made after exclusion of other
possible causes of existing symptoms.
As ultrasound examination, although planned for all
patients, was limited and sometimes connected with wait-
ing lists, it was performed when it was possible to be
carried out immediately, especially when it was necessary
for decision regarding the type of therapy.
Out of 1679 patients with CVD deﬁned by C of CEAP
classiﬁcation, BMI (kg m2) could not be calculated in 277
subjects (missing data on body height and/or weight). Of
patients in whom BMI was calculated (1402 persons), 1116
patients had primary, 237 had secondary and 49 had
congenital CVD. For the purpose of the present analysis, the
ﬁnal study group comprised 1116 patients with primary
CVD.Statistical analysis
Categorical variables were presented by counts and
percentages and continuous variables were described as
means  standard deviation (SD). Univariate and multi-
variate logistic regression analyses were used for estimating
the association of overweight and obesity with CEAP C
categories of CVD and other characteristics of CVD patients.
All variables that were, according to univariate analysis,
associated with overweight or obesity in CVD patients at
a level of P  0.10 were included in the multivariate
analysis. Several models of multivariate analyses were used:
Model 1 e with CEAP C0seC6 as discontinuous variable;
Model 2 e with CEAP C4eC6 versus C0seC3 and Model 3 ewith CEAP C3eC6 versus C0seC2. Additionally, all patients
who had varicose veins (C2 and varicose vein patients in
C3eC6 categories) were compared with C0seC1 categories.
All P values are based on two-tailed tests, and P < 0.05 was
considered as signiﬁcant. Data were analysed using Statis-
tical Package for Social Sciences (SPSS) package version 19.RESULTS
The study comprised 1116 subjects with primary chronic
venous diseases, 384 (34.4%) men and 732 (65.6%) women.
Among them 118 (30.7%) men and 346 (47.3%) women
were normal weight patients (BMI < 25.0 kg m2), 209
(54.4%) men and 267 (36.5%) women were overweight
(BMI ¼ 25.0e29.9 kg m2) and 57 (14.8%) men and 119
(16.3%) women were obese (BMI  30.0 kg m2) e P for
sex differences <0.001. Mean age  standard deviation was
47.1  16.4 in normal weight, 55.4  12.9 in overweight
and 52.3  14.9 years in obese patients (P < 0.001). As the
groups deﬁned according to BMI signiﬁcantly differed by
age and sex, all further comparisons between them were
age- and sex-adjusted.
Overweight and obese patients signiﬁcantly differed in
the frequency of the CEAP C categories of CVD from normal
weight patients (Table 1). CEAP C3eC6 categories were
more frequent among overweight and obese than among
normal weight patients.
Characteristics from the personal and parental history of
patients with CVD, which, according to univariate logistic
regression analysis, signiﬁcantly (P  0.10) differed
between BMI groups, are presented in Table 2. In
comparison with normal weight patients, both overweight
and obese had signiﬁcantly more frequently personal
history of diabetes, high blood pressure, skeletal or joint
disease in legs and malignant disease and parental history
of ankle ulcer. They were also less frequently physically
active. In addition, those who were obese had, in compar-
ison with normal weight patients, signiﬁcantly more
frequently personal history of superﬁcial and deep venous
thrombosis, pulmonary embolism, heart failure, inﬂamma-
tory bowel disease and emphysema or chronic obstructive
pulmonary disease and parental history of swollen legs,
superﬁcial venous thrombosis and pulmonary embolism. In
overweight, peripheral arterial occlusive disease was
signiﬁcantly more frequent than in normal weight patients.
According to multivariate logistic regression analyses
(Table 3), after adjustment for possible confounding vari-
ables, obesity was signiﬁcantly related to advanced CEAP C
categories of CVD when CEAP C0seC6 was included in the
model as a discontinuous variable (Model 1) and when C3e
C6 categories were compared with C0seC1. Signiﬁcant
association between overweight and advanced CEAP C
categories of CVD was found only when the C3eC6 cate-
gories were compared with C0seC2 (Table 3).
In 628 (56.4%) patients, Doppler ultrasound or duplex
scanning was performed (Table 4). There were no signiﬁcant
differences in the proportions of patients with and without
reﬂux according to BMI, but both superﬁcial and deep
Table 1. CEAPeC categories of patients with primary chronic venous disease by body mass index.
Body mass index
CEAP C
categories
Mean
BMI  SD
<25 kg/m2
number (%)
25.0e29.9 Kg/m2
number (%)
30 kg/m2
number (%)
Total
number
CEAP C0s 26.1  2.9 3 (20.0) 11 (73.3) 1 (6.7) 15
CEAP C1 23.3  4.2 45 (75.0) 9 (15.0) 6 (10.0) 60
CEAP C2 24.9  3.6 254 (52.2) 194 (39.8) 39 (8.0) 487
CEAP C3 27.2  4.8 55 (30.4) 82 (45.3) 44 (24.3) 181
CEAP C4 26.9  4.0 83 (35.5) 108 (46.2) 43 (18.4) 234
CEAP C5 28.7  4.3 10 (19.2) 24 (46.2) 18 (34.6) 58
CEAP C6 28.7  4.7 14 (16.1) 48 (55.2) 25 (28.7) 87
P valuea <0.001b <0.001c
Total 26.1  4.3 464 (41.6) 476 (42.7) 176 (15.9) 1116
BMI e body mass index; SD e standard deviation.
a According to univariate logistic regression analysis, adjusted for age and sex.
b For comparison between BMI ¼ 25.0e29.9 kg/m2 group and BMI < 25 kg/m2 group.
c For comparison between BMI  30 kg/m2 group and BMI < 25 kg/m2 group.
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overweight and obese patients rather than in normal weight
patients. In 72 (11.4%) patients, both reﬂux and obstruction
were present, more frequently, but not signiﬁcantly, inTable 2. Some characteristics from personal and parental history of p
Body mass index
Variable <25 kg/m2 Number (%) 25.0e29.9 k
Personal history of:
Venous thrombosis
Superﬁcial 104 (32.7) 146 (46.1)
Deep 13 (15.5) 20 (39.2)
Pulmonary embolism 1 (10.0) 3 (30.0)
Diabetes 23 (16.7) 78 (56.5)b
High blood pressure 112 (24.9) 228 (50.7)b
Heart failure 42 (27.1) 74 (47.7)
Peripheral arterial
occlusive disease 10 (47.6) 7 (33.3)a
Skeletal or joint
disease in legs 64 (26.6) 123 (51.0)d
Inﬂammatory bowel
disease 3 (23.1) 5 (38.5)
Emphysema or
COPD 8 (23.5) 13 (38.2)
Malignant disease 5 (14.3) 21 (60.0)a
Regular exercise 210 (50.0) 165 (39.3)a
Parental history of:
Swollen legs 159 (42.3) 150 (39.9)
Ankle ulcers 18 (15.9) 68 (60.2)b
Superﬁcial venous
thrombosis 72 (37.1) 82 (42.3)
Pulmonary embolism 8 (33.3) 7 (29.2)
Total 464 (41.6) 476 (42.7)
COPD e chronic obstructive pulmonary disease. P values for compariso
and for comparison between BMI  30 kg/m2 and BMI < 25 kg/m2 gro
age and sex:
a P < 0.05.
b P < 0.001.
c P  0.10.
d P < 0.01.
e Only variables for which, according to univariate logistic regression an
presented in the table. There were no signiﬁcant differences in numbe
two legs affected), renal insufﬁciency (1.5%), and parental history of an
and deep venous thrombosis (7.4%).overweight (13.3%) and obese (14.1%) than in normal weight
(8.4%) patients (P ¼ 0.324 and P ¼ 0.336, respectively).
In multivariate analyses, obstruction was not found to be
independently related to overweight and obesity in any ofatients with primary chronic venous disease by body mass indexe
g/m2 Number (%) 30 kg/m2 Number (%) Total number
67 (21.1)a 317
18 (35.3)a 51
6 (60.0)a 10
37 (26.8)b 138
110 (24.4)b 450
39 (25.2)c 155
4 (19.0) 21
54 (22.4)a 241
5 (38.5)a 13
13 (38.2)a 34
9 (25.7)a 35
45 (10.7)d 420
67 (17.8)c 376
27 (23.9)b 113
40 (20.6)a 194
9 (37.5)c 24
176 (15.8) 1116
n between BMI ¼ 25.0e29.9 kg/m2 and BMI < 25 kg/m2 groups,
ups, according to univariate logistic regression analysis, adjusted for
alysis, statistically signiﬁcant (P  0.10) differences were found are
r of legs affected by chronic venous disease (87.9% of patients had
y leg problems (71.6%), spider veins (24.3%), varicose veins (55.2%)
Table 3. Association of CEAPeC categories of primary chronic venous disease with overweight and obesity according to miltivariate logistic
regression analysis.
Model of
multivariate analysis
CEAPeC categories Overweighta P value Obesityb P value
Odds ratio (95% CI) Odds ratio (95% CI)
Model 1. C0s e C6 1.11 (1.00e1.25) 0.075 1.49 (1.28e1.75) <0.001
Model 2. C4eC6 vs. C0s e C3 1.05 (0.76e1.47) 0.753 1.51 (0.96e2.37) 0.072
Model 3. C3eC6 vs. C0s e C2 1.38 (1.02e1.87) 0.034 3.31 (2.12e5.17) <0.001
a In the models of multivariate analyses were included: age, sex, CEAP C categories, personal history of diabetes, high blood pressure,
peripheral arterial occlusive disease, skeletal or joint disease in legs and malignant disease, regular exercise, and parental history of ankle
ulcers.
b In the models of multivariate analyses were included: age, sex, CEAP C categories, personal history of superﬁcial venous thrombosis,
deep venous thrombosis, pulmonary embolism, diabetes, high blood pressure, heart failure, skeletal or joint disease in legs, inﬂammatory
bowel disease, emphysema or chronic obstructive pulmonary disease and malignant disease, regular exercise, parental history of swollen
legs, ankle ulcers, superﬁcial venous thrombosis and pulmonary embolism.
296 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 3 March/2013three models used. After inclusion of the obstruction in the
multivariate models, association of overweight and obesity
with the CEAP C categories did not substantially change. The
exceptions were association between overweight and CEAP
C3eC6 categories (odds ratio (OR) ¼ 1.66, 95%conﬁdence
interval (CI) ¼ 1.00e2.76, P ¼ 0.051) and association
between obesity and CEAP C4eC6 categories (OR ¼ 2.14,
95% CI ¼ 1.01e4.52, P < 0.05).
There were no signiﬁcant differences according to BMI
when all patients who had varicose veins (C2 and varicose
veins patients in C3eC6 categories e total of 857 patients)
were compared with C0seC1 categories (75 patients). Distri-
bution of patients with varicose veins was 78.9% in normal
weight, 77.7% in overweight and 68.7% in obese patients.DISCUSSION
In the present study, the advanced CEAP C categories of CVD
were more frequent in the overweight and obese patients, in
comparisonwith normalweight patients.This associationwasTable 4. Results of Doppler ultrasound or a duplex scanning in
patients with primary chronic venous disease by body mass index.
Body mass index
Variable <25 kg/m2
number (%)
25.0e29.9
kg/m2
number (%)
30 kg/m2
number (%)
Total
number
Reﬂux:
Superﬁcial 158 (40.5) 174 (44.6) 58 (14.9) 390
Deep 4 (26.7) 8 (53.3) 3 (20.0) 15
Perforators 40 (39.2) 46 (45.1) 16 (15.7) 102
P valuea 0.473b 0.406c
Obstuction:
Superﬁcial 25 (29.8) 46 (54.8) 13 (15.5) 84
Deep 4 (19.0) 10 (47.6) 7 (33.3) 21
P valuea 0.035b 0.026c
Total
number
231 (37.7) 284 (46.4) 97 (15.8) 612
a According to univariate logistic regression analysis, adjusted for
age and sex.
b For comparison between BMI ¼ 25.0e29.9 kg/m2 group and
BMI < 25 kg/m2 group.
c For comparison between BMI  30 kg/m2 group and
BMI < 25 kg/m2 group.more pronounced in obese patients and it was independent
from age, sex and some other postulated risk factors.
Association between obesity and CVD, especially in
patients with severe skin changes, was found in the
majority of studies, but not in all of them. Danielsson et al.9
found signiﬁcant association between BMI and the clinical
severity according to C of CEAP classiﬁcation. In the San
Diego Population Study,10 increased waist circumference
was a risk factor for severe venous disease in men and
women and increased weight was a risk factor for moderate
venous disease, but only in women. In the study conducted
by Musil et al.,11 BMI together with age was a signiﬁcant
predictor of clinical grade of CVD according to C of the CEAP
classiﬁcation e obese patients have clinically more severe
venous disease. On the contrary, a French epidemiological
study12 did not show any relationship between the CEAP C
category and obesity at least in male patients. The differ-
ences observed between obese, overweight and normal
weight patients in the severity of the disease were age-
linked e obese patients were older than the other patients
and CVD was more severe with age.
The mechanisms of association between obesity and CVD
are still unclear. On the one hand, this correlation is explained
by chronically inﬂammatory processes, affected by the lip-
ometabolism of obese and the metabolic syndrome.15 In the
present study, we did not obtain data about the lipid status of
patients and the presence of metabolic syndrome. However,
association of overweight and obesity with the CEAP C
categories of CVD remained after adjustment on diabetes and
hypertension, which are related to metabolic syndrome, and
independently of other factors associated with increased
BMI. The chronically inﬂammatory processes can also
promote the frequency and manifestation of thrombosis15,16
and, according to Scott et al.17 and Mohr et al.,18 venous
thromboembolism (VTE) is the most important secondary
cause of CVD. Obesity has been considered as a risk factor for
VTE disease.19,20 In a large Danish prospective study,21 all
measurements of obesity (body weight, BMI, waist circum-
ference, hip circumference and total body fat mass) were
predictors of the risk for VTE. In addition to inﬂammation, the
association between obesity and both arterial and venous
thrombosis has been explained by several othermechanisms:
the action of adipocytokines from adipose tissue, increased
activity of the coagulation cascade and decreased activity of
H.D. Vlajinac et al. 297the ﬁbrinolytic cascade, increased oxidative stress, endo-
thelial dysfunction and dyslipidaemia and glucose intoler-
ance in association with metabolic syndrome.16 However,
Brækkan et al.22 recently reported that VTEwas related to age
and obesity, but not to traditional atherosclerotic risk factors,
such as hypertension, high levels of triglyceride and total
cholesterol, low levels of high-density lipoprotein cholesterol,
diabetes mellitus and smoking. In the present study, venous
thrombosis and pulmonary embolism were more frequently
present in obese and overweight than in normal weight
patients, but these associations were not independent of
other factors.
The other possible explanation is that correlation
between obesity and CVD and its severity is a result of an
elevated intra-abdominal pressure (IAP), leading to greater
reﬂux, increased vein diameter and venous pressures.23 The
study of Willenberg et al.24 showed that lower limb venous
ﬂow parameters differ signiﬁcantly between healthy obese
(BMI > 30.0 kg m2) and non-obese (BMI < 25.0 kg m2)
individuals e the diameter of the femoral vein and venous
peak velocity were signiﬁcantly greater in obese individuals;
velocities amplitude and shear stress showed signiﬁcantly
higher values in non-obese individuals. The authors stated
that these ﬁndings support the mechanical role of abdom-
inal adipose tissue potentially leading to elevated risk for
both VTE and chronic venous insufﬁciency (CVI).
In the present study we have no such details about
venous homodynamic in the observed patients, but there
were no signiﬁcant differences in the presence of venous
reﬂux between groups deﬁned according to BMI. Obstruc-
tion was signiﬁcantly more frequently found in overweight
and in obese patients in comparison with normal weight
patients, but obstruction was not related to increased BMI
independently of other factors, and did not substantially
affect the association of overweight and obesity with the
CEAP C categories of CVD.
Iannuzzi et al.25 found that increased weight increases
the risk of varicose veins in postmenopausal women, but no
association was found between BMI and plethysmographic
measurements of venous parameters (venous capacitance
and outﬂow). In the Danielsson et al.9 study, the signiﬁcant
association between BMI and the clinical severity of CVD
(CEAP C categories) was independent of reﬂux measure-
ments indicating that the effect of overweight may involve
a mechanism separate from local effects on venous ﬂow.
Patients with BMI  25.0 kg m2 were more likely to have
skin changes and ulcers than non-obese patients despite
similar values for total reﬂux time and total peak reverse
ﬂow velocity.9 Typical skin changes without any venous
reﬂux are classiﬁed as so-called hydrostatic ulceration.26
Bjellerup26 found that among patients attending a speci-
alised leg ulcer clinic, 21% had hydrostatic ulceration. In the
San Diego Population Study of CVD, Criqui et al.27 found
that 25.9% of legs with trophic changes (CEAP C4eC6) had
normal venous function. Padbereg et al.28 also found that in
patients with severe CVI (CEAP C4eC6) and with class III
obesity (BMI > 40.0 kg m2) approximately two-thirds of
the limbs (64%) had no anatomic evidence of venousdisease. Increasing CEAP category was associated with an
increasing BMI suggesting that the obesity itself contributes
to the morbidity,28 but the pathomechanism causing
hydrostatic ulcers in obese in still unclear.14 However, in the
present study, among patients in whom Doppler ultrasound
or duplex scanning was performed, all patients in CEAP C5
and C6 categories and 88.0% of patients in the CEAP C4
category had reﬂux or/and obstruction.
The fact that in the present study overweight and obesity
were not associated with varicose veins (patients in the
CEAP C2 category and varicose veins patients in the C3eC6
categories) needs further investigation in order to conﬁrm
and to explain this ﬁnding.
The limitation of the present study is its cross-sectional
design. The better approach would be to follow up patients
with CVD to see whether aggravation of the disease is more
pronounced in those who are overweight or obese. Another
limitation is the fact that ultrasound examination was not
performed in all patients.
In conclusion, we found the statistically signiﬁcant posi-
tive association of the CEAP C categories with overweight
and obesity. This association was more pronounced for
obesity and it was independent of age, sex and some other
postulated risk factors. In comparison with normal weight
patients, overweight and obese patients did not differ in the
presence of venous reﬂux. In univariate analysis, venous
obstruction was related to overweight and obesity but this
association did not substantially affect the relationship
between increased BMI and CEAP C categories. Further
studies are needed to explain the nature of this association.
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